#pharmanews — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #pharmanews, aggregated by home.social.
-
DATE: August 31, 2026 at 11:13AM
SOURCE: PSYCHIATRIC TIMESDirect article link at end of text block below.
As August comes to a close, be sure to check out all the updates on psychopharmacology from this month: https://t.co/AqxtcD2JgL
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at Articles can be found at https://www.psychiatrictimes.com/news".
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #psychotherapist #Psychopharmacology #AugustUpdates #PharmaNews #MentalHealthScience #ResearchNews
-
ANTITRUST Biogen probed by Italy over MS drug competition cinquewnews.blogspot.com/2026/05/biog... #Antitrust #Biogen #MultipleSclerosis #MSDrug #PharmaNews #ItalianAntitrust #CompetitionLaw #HealthcareIndustry #Biotech #Natalizumab #Sandoz #DrugMarket #EUCompetition #Pharmaceuticals #MedicalNews
Biogen probed by Italy over MS... -
New lawsuits claim Ozempic and other GLP-1 drugs may be linked to NAION-related vision loss. Patients allege unexpected blindness risks. Read More Here: https://www.jdsupra.com/legalnews/ozempic-blindness-lawsuits-legal-claims-1081107/
#Ozempic #GLP1 #NAION #VisionLoss #DrugSafety #PharmaNewshttps://www.jdsupra.com/legalnews/ozempic-blindness-lawsuits-legal-claims-1081107/
-
5 neuro data readouts to watch in the second half of 2024 — GSK moves to new HQ in return to central London — AbbVie led the way in paying doctors to pitch its drugs last year —http://bit.ly/w28kSd #clinicaltrials #neurology #gsk #london #abbvie #physicians #physicianpayments #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Chronic kidney disease market estimated to grow at 19.6%, driven by pipeline agents aimed at unmet needs—Lexicon Pharmaceuticals resubmits sotagliflozin NDA for type 1 diabetes —Former Stimwave CEO gets 6 years in prison for fake device scheme—http://bit.ly/w28kSd #chronickidneydisease #kidneydisease #medtech #type1diabetes #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
AbbVie's tight grip on Humira market raises concerns about biosimilars—As biotech recovers, venture firms’ preferences appear to shift — Boehringer, Zealand heat up MASH race with strong phase II data—http://bit.ly/w28kSd #abbvie #humira #biosimilars #funding #mash #nash #boehringeringelheim #ipos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Biogen to buy Human Immunology Biosciences in deal worth up to $1.8B—Boehringer pays OSE $42M to expand collab into cardio disease, grab new asset —9 top biopharma CEO-to-employee pay gaps --http://bit.ly/w28kSd #biogen #mergersandacquisitions #boehringeringelheim #cardiovasculardisease #pharmaceos #executivecompensation #paygap #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma